412 results
Breakthrough studies: Key abstracts on PCI, TAVI and mitral valve repair
04 Oct 2024 – From AICT-AsiaPCR 2024
Discover the cutting-edge research and innovative solutions presented in the 'Best Abstracts of AICT-AsiaPCR 2024' session. This curated selection showcases the latest advancements in interventional cardiology, from groundbreaking comparisons of transcatheter mitral valve repair techniques to the impact of cerebral embolic protection devices in TAVI procedures....
Managing severe calcified LAD lesions in STEMI: Insights from three cases
04 Oct 2024 – From AICT-AsiaPCR 2024
Dive into this compelling presentation highlighting three challenging STEMI cases involving severe proximal LAD calcified stenosis. Witness the ingenuity of interventional strategies as the presenter explores how drug-coated balloons can be a viable alternative to stents in acute MI management. Don't miss this opportunity to deepen...
Best clinical cases: Stent degloving, valve defects, and calcified lesions
04 Oct 2024 – From AICT-AsiaPCR 2024
Immerse yourself in a captivating collection of best clinical cases from AICT-AsiaPCR 2024. Witness the ingenuity and expertise of interventional cardiologists as they navigate complex scenarios, from addressing stuck prosthetic mitral valves to managing unconventional calcified lesions. Discover unique approaches, innovative solutions, and valuable lessons that...
Mechanical circulatory support in cardiogenic shock: should it become routine?
12 Sep 2024
Discover the current use of mechanical circulatory support in patients with myocardial infarction and cardiogenic shock.
IVORY FINALE study: Low-dose interleukin-2 for the reduction of vascular inflammation in ACS - Clinical outcomes and follow-up
31 Aug 2024
Aaysha Cader interviews Rouchelle Sriranjan about the results of the IVORY and IVORY 2 trials which she presented at the ESC Congress 2024 in London.
The trials examined low-dose interleukin-2 therapy to reduce arterial inflammation in acute coronary syndrome patients. The study found a 7.7% reduction in arterial inflammation...

Author

Author
Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial
27 Aug 2024
The rationale for this study was to provide direct evidence of colchicine's effects on plaque stabilization, particularly by assessing changes in plaque characteristics using optical coherence tomography (OCT).

Reviewer

Reviewer
EARTH-STEMI - Complete vs. culprit-only revascularisation in older STEMI patients
03 Sep 2024
Aaysha Cader interviews Gianluca Campo about the EARTH-STEMI trial he presented at ESC Congress 2024 in London.
This meta-analysis aimed to evaluate a large cohort of STEMI patients, predominantly comorbid, with a mean age of 79 and extended long-term follow-up. The key findings revealed that complete revascularisation reduced the...

Author

Author
PCRonline @ ESC Congress 2024: the interventional cardiology perspective!
26 Jul 2024
What was new and hot in interventional cardiology at #ESCCongress 2024!
Completeness of revascularisation in acute coronary syndrome patients with multivessel disease
28 Jun 2024
Explore evidence on complete revascularisation for patients with STEMI or NSTEMI and multivessel disease, and provide insights into the roles of intracoronary guidance by physiology and imaging.
Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial
20 Jun 2024
This trial found that, in ACS patients undergoing PCI, DP-DES and BP-DES had similar patient-oriented outcomes at three years, but BP-DES had higher device-oriented composite outcomes, mainly due to increased TLR risk.

Reviewer